Barclays PLC cut its holdings in American Well Co. (NYSE:AMWL - Free Report) by 95.2% during the third quarter, according to its most recent Form 13F filing with the SEC. The fund owned 7,108 shares of the company's stock after selling 140,251 shares during the period. Barclays PLC's holdings in American Well were worth $67,000 at the end of the most recent reporting period.
Other hedge funds also recently added to or reduced their stakes in the company. Point72 DIFC Ltd lifted its stake in American Well by 1,418.5% during the 2nd quarter. Point72 DIFC Ltd now owns 103,457 shares of the company's stock worth $34,000 after acquiring an additional 96,644 shares in the last quarter. Cubist Systematic Strategies LLC increased its stake in American Well by 7,673.8% during the second quarter. Cubist Systematic Strategies LLC now owns 184,083 shares of the company's stock worth $60,000 after purchasing an additional 181,715 shares during the period. BNP Paribas Financial Markets acquired a new stake in shares of American Well during the third quarter worth about $95,000. PDT Partners LLC purchased a new position in shares of American Well in the third quarter valued at approximately $107,000. Finally, Point72 Asia Singapore Pte. Ltd. grew its holdings in shares of American Well by 2,690.2% in the second quarter. Point72 Asia Singapore Pte. Ltd. now owns 419,841 shares of the company's stock valued at $136,000 after purchasing an additional 404,794 shares in the last quarter. 56.05% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
Several equities analysts have commented on AMWL shares. Needham & Company LLC reissued a "hold" rating on shares of American Well in a research report on Thursday, October 31st. Morgan Stanley decreased their target price on American Well from $20.00 to $10.50 and set an "equal weight" rating for the company in a report on Tuesday, December 17th.
View Our Latest Research Report on AMWL
American Well Price Performance
Shares of AMWL traded down $0.04 during midday trading on Friday, reaching $7.25. The stock had a trading volume of 22,283 shares, compared to its average volume of 38,847. The company's fifty day simple moving average is $8.41 and its two-hundred day simple moving average is $8.63. The company has a market cap of $111.07 million, a price-to-earnings ratio of -0.50 and a beta of 1.11. American Well Co. has a 1-year low of $5.00 and a 1-year high of $29.00.
American Well Company Profile
(
Free Report)
American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Converge, a cloud-based platform that enables health providers, payers, and innovators to provide in-person, virtual and automated care; and delivers virtual primary care, post-discharge follow-up, chronic condition management, virtual nursing, e-sitting, on-demand and scheduled virtual visits, specialty consults, automated care, and behavioral health, as well as specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care to patients and members.
Featured Stories
Before you consider American Well, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and American Well wasn't on the list.
While American Well currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
